Evidence map›Paper›PMID 34572347›Full record

ArticleBiomedicines2021

A Senescence Bystander Effect in Human Lung Fibroblasts.

David W Waters, Michael Schuliga, Prabuddha S Pathinayake, Lan Wei, Hui-Ying Tan, Kaj E C Blokland, Jade Jaffar, Glen P Westall, Janette K Burgess, Cecilia M Prêle and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Current issues in molecular biology · 2025
    Article
  5. Article
  6. Review
  7. ModulatingAging · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

David W WatersSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Michael SchuligaSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.ORCID 0000-0001-6742-5028
Prabuddha S PathinayakeSchool of Medicine and Public Health, University of Newcastle, Callaghan, NSW 2308, Australia.ORCID 0000-0002-4947-5918
Lan WeiSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.ORCID 0000-0002-4302-0613
Hui-Ying TanSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Kaj E C BloklandSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.ORCID 0000-0002-1807-6359
Jade JaffarAllergy, Immunology and Respiratory Medicine, Alfred Hospital, Melbourne, VIC 3004, Australia.
Glen P WestallAllergy, Immunology and Respiratory Medicine, Alfred Hospital, Melbourne, VIC 3004, Australia.
Janette K BurgessUniversity Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, 9713 GZ Groningen, The Netherlands.ORCID 0000-0001-9868-9966
Cecilia M PrêleCentre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, University of Western Australia, Nedlands, WA 6009, Australia.
Steven E MutsaersCentre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, University of Western Australia, Nedlands, WA 6009, Australia.ORCID 0000-0002-2615-8338
Christopher L GraingeSchool of Medicine and Public Health, University of Newcastle, Callaghan, NSW 2308, Australia.
Darryl A KnightSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
University of Newcastle Australia · AUThe Alfred Hospital · AUThe University of Western Australia · AUUniversity Medical Center Groningen · NLNational Health and Medical Research Council · AUProvidence Health Care Research Institute · CA

Funding

Lung Foundation of Australia David Wilson Scholarship NoneNational Health and Medical Research Council 1099569
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic disease characterised by a dense fibrosing of the lung parenchyma. An association between IPF and cellular senescence is well established and several studies now describe a higher abundance of senescent fibroblasts and epithelial cells in the lungs of IPF patients compared with age-matched controls. The cause of this abnormal accumulation of senescent cells is unknown but evidence suggests that, once established, senescence can be transferred from senescent to non-senescent cells. In this study, we investigated whether senescent human lung fibroblasts (LFs) and alveolar epithelial cells (AECs) could induce a senescent-like phenotype in "naïve" non-senescent LFs in vitro. Primary cultures of LFs from adult control donors (Ctrl-LFs) with a low baseline of senescence were exposed to conditioned medium (CM) from: (i) Ctrl-LFs induced to become senescent using H

Indexed as

collagenidiopathic pulmonary fibrosis (IPF)lung fibroblastssenescence

Identifiers

PMID34572347
PMCPMC8470192
OpenAlexW3197606384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.